Apple today seeded the release candidates of iOS 26.4 and iPadOS 26.4 to developers and public beta testers for final testing.
Ever wondered why some iOS mobile apps cost as much as a Manhattan luxury apartment while others are built for the price of a used sedan? The truth is simple and straightforward: app pricing is not a ...
Feb 18 (Reuters) - Unnatural Products said on Wednesday it has signed a licensing agreement with Novartis (NOVN.S), opens new tab to develop macrocyclic peptide-based therapies for a cardiovascular ...
SANTA CRUZ, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, today ...
Apple's iOS 26.4 beta is now available, just one week after the tech giant launched iOS 26.3. Released on Monday, the iOS 26.4 beta doesn't include the long-awaited Gemini-powered Siri, which was ...
Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing Pfizer (PFE.N), opens new tab access to its technology that boosts immune responses to vaccines for use in up to ...
ZUG, Switzerland--(BUSINESS WIRE)--Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, is thrilled to announce the signing of a ...
Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results